Evaluation of implicit Q-learning shows robust insulin dosing policies across diabetes types and regions.
Offline reinforcement learning enables learning insulin dosing policies from historical data without risky patient interactions. This study evaluates Implicit Q-Learning (IQL) on three real-world continuous glucose monitoring datasets: OhioT1DM (USA, type 1), ShanghaiT1DM (China, type 1), and ShanghaiT2DM (China, type 2). IQL achieved time in range of 68.5%, 54.3%, and 78.9% respectively. Cross-dataset transfer experiments demonstrated exceptional generalization with over 98% performance retention across geographic regions and diabetes types, suggesting that IQL captures fundamental glucose-insulin dynamics rather than dataset-specific patterns. Ablation studies validated our clinically-motivated reward function design, while sensitivity and robustness analyses confirmed algorithm stability across hyperparameter choices and data quality perturbations.
No takes yet. Share an insight, caveat, or question.
Mi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: